Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
OMI 
Owens & Minor Inc (OMI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: OMI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
6 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $5.7
1 Year Target Price $5.7
| 2 | Strong Buy |
| 0 | Buy |
| 2 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -50.35% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 200.33M USD | Price to earnings Ratio - | 1Y Target Price 5.7 |
Price to earnings Ratio - | 1Y Target Price 5.7 | ||
Volume (30-day avg) 6 | Beta 1.36 | 52 Weeks Range 2.45 - 15.54 | Updated Date 12/6/2025 |
52 Weeks Range 2.45 - 15.54 | Updated Date 12/6/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -5.69 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -12.45% | Operating Margin (TTM) 8.08% |
Management Effectiveness
Return on Assets (TTM) 3.75% | Return on Equity (TTM) -196.39% |
Valuation
Trailing PE - | Forward PE 3.15 | Enterprise Value 2364877144 | Price to Sales(TTM) 0.02 |
Enterprise Value 2364877144 | Price to Sales(TTM) 0.02 | ||
Enterprise Value to Revenue 0.22 | Enterprise Value to EBITDA 8.54 | Shares Outstanding 77346594 | Shares Floating 61173421 |
Shares Outstanding 77346594 | Shares Floating 61173421 | ||
Percent Insiders 3.36 | Percent Institutions 97.28 |
Upturn AI SWOT
Owens & Minor Inc
Company Overview
History and Background
Owens & Minor, Inc. was founded in 1882 in Richmond, Virginia. Originally a wholesale drug company, it evolved into a leading global healthcare solutions company focused on supply chain services and product manufacturing.
Core Business Areas
- Products & Healthcare Services: This segment distributes medical and surgical supplies, and provides supply chain solutions to healthcare providers.
- Global Products: This segment manufactures and sources medical devices and surgical products, including surgical procedure trays and infection prevention products.
Leadership and Structure
The company is led by Edward A. Pesicka, President & CEO. The organizational structure includes various departments such as finance, operations, sales, marketing, and human resources.
Top Products and Market Share
Key Offerings
- Medical and Surgical Supplies: Owens & Minor distributes a wide range of medical and surgical supplies, including gloves, gowns, masks, surgical instruments, and wound care products. Market share data is difficult to pinpoint precisely but these supply chains are in competition with Cardinal Health and Medline Industries.
- Surgical Procedure Trays: Owens & Minor manufactures and distributes customized surgical procedure trays. These trays contain all the necessary instruments and supplies for a specific surgical procedure. Competition includes Steris and BD (Becton, Dickinson and Company).
- Supply Chain Solutions: Owens & Minor provides supply chain management services, including distribution, warehousing, inventory management, and logistics. Competitors include Cardinal Health and McKesson.
Market Dynamics
Industry Overview
The healthcare supply chain industry is experiencing growth driven by an aging population, increasing demand for healthcare services, and technological advancements. The industry is also facing challenges such as rising costs, supply chain disruptions, and regulatory changes.
Positioning
Owens & Minor is a leading player in the healthcare supply chain industry, offering a comprehensive range of products and services. Its competitive advantages include its established infrastructure, strong customer relationships, and extensive product portfolio.
Total Addressable Market (TAM)
The global healthcare supply chain market is expected to reach hundreds of billions of dollars. Owens & Minor holds a substantial, but not dominant, position within this TAM.
Upturn SWOT Analysis
Strengths
- Established Infrastructure
- Strong Customer Relationships
- Extensive Product Portfolio
- Global Presence
- Vertically Integrated Manufacturing
Weaknesses
- High Debt Levels
- Complex Supply Chain
- Dependence on Key Customers
- Profit Margins Sensitive to Pricing Pressures
- Integration Challenges with Acquired Businesses
Opportunities
- Expanding Healthcare Market
- Technological Advancements
- Strategic Acquisitions
- Growth in Emerging Markets
- Increased Demand for Home Healthcare
Threats
- Rising Costs
- Supply Chain Disruptions
- Regulatory Changes
- Intense Competition
- Economic Downturn
Competitors and Market Share
Key Competitors
- Cardinal Health (CAH)
- McKesson (MCK)
- Medline Industries (Privately Held)
Competitive Landscape
Owens & Minor faces intense competition from larger and more diversified players. It differentiates itself through its focus on supply chain solutions and its vertically integrated manufacturing capabilities.
Major Acquisitions
Apria Healthcare
- Year: 2022
- Acquisition Price (USD millions): 1450
- Strategic Rationale: Expands Owens & Minor's presence in the home healthcare market.
Growth Trajectory and Initiatives
Historical Growth: Historical growth analysis requires access to recent financial statements.
Future Projections: Future projections depend on market conditions and company strategy.
Recent Initiatives: Recent strategic initiatives include acquisitions and partnerships.
Summary
Owens & Minor is a significant player in the healthcare supply chain with a long history. While its vertically integrated manufacturing and strong customer relationships are strengths, it faces challenges related to debt and intense competition. Recent acquisitions have broadened its market presence, but it must manage integration effectively and navigate economic headwinds. Overall the company has a fair market share.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Financial News Sources
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Owens & Minor Inc
Exchange NYSE | Headquaters Glen Allen, VA, United States | ||
IPO Launch date 1988-12-16 | President, CEO & Director Mr. Edward A. Pesicka | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 23200 | Website https://www.owens-minor.com |
Full time employees 23200 | Website https://www.owens-minor.com | ||
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.